Lorbrexen 100 mg (Lorlatinib):

Lorbrexen 100 mg contains a potent tyrosine kinase inhibitor called lorlatinib. Indicated for the treatment of certain types of advanced or metastatic non-small cell lung cancer (NSCLC). The mechanism of action of lerlatinib is to inhibit essential proteins involved in the growth of cancer cells. Those with genetic defects such as ROS1 and ALK. Lorbrexen has been approved by regulatory agencies and has demonstrated efficacy in treating patients who have not responded well to prior treatments. Mood swings, high cholesterol and fatigue are common side effects. As with any medication, patients should carefully weigh the pros and cons of each option with their physician to determine the best course of action for their unique situation.

What is lorbrexen and how does it work:

Lorlatinib is an anti-cancer drug made by Pfizer, which also goes by the names Lorbrena and Lorvicua. Lorbrexen 100 mg is an oral inhibitor of the enzymes ROS1 and ALK, which are involved in cancer development. Lorlatinib has significant efficacy against the ALK G1202R mutation. Mostly used to treat ALK-positive metastatic non-small-cell lung cancer (NSCLC).

Generic Lorlatinib 100 mg

The drug lerlatinib is mainly use to treat particular cancers, including non-small cell lung cancer (NSCLC) with specific genetic abnormalities including ALK and ROS1. It is a member of the tyrosine kinase inhibitor (TKI) medication class, which acts by preventing the synthesis and invasion of cancer cells by certain proteins.

Lorlatinib is available as tablets; the recommended dosage is 100 mg once daily, and it is typically administered orally. However, dosages can change based on the particular malignancy being treat as well as circumstances unique to each patient.

Like any drug, lorlatinib can have minor to severe side effects. These can include edema, tiredness, diarrhea, increased liver enzymes, and cognitive problems. Before beginning treatment, patients should talk with their healthcare provider about any possible adverse effects and interactions.

For patients with ALK and ROS1 positive NSCLC, lorlatinib offers new hope and better outcomes. It is a major improvement in the targeted therapy of specific tumors.

How to order IEB Pharma medicine…?

Ordering our IEB Pharma Medicines is easy. Currently there is no automated ordering system on our website, we offer various options for ordering IEB Pharma Medicines.

WhatsApp: You can send a message by clicking on our WhatsApp button, a customer service representative of ieb Pharma will assist you in placing your order.

Telegram/Messenger/WeChat: If you want to place an order on our Facebook messenger or Telegram or WeChat, then you can easily place an order by clicking on our message option button.

Email: You can message us at [email protected] for details about your order. We answer your call as soon as we can.